TY - JOUR
T1 - Long-term use of β-carotene, retinol, lycopene, and lutein supplements and lung cancer risk
T2 - Results from the vitamins and lifestyle (vital) study
AU - Satia, Jessie A.
AU - Littman, Alyson
AU - Slatore, Christopher G.
AU - Galanko, Joseph A.
AU - White, Emily
PY - 2009/4
Y1 - 2009/4
N2 - High-dose β-carotene supplementation in high-risk persons has been linked to increased lung cancer risk in clinical trials; whether effects are similar in the general population is unclear. The authors examined associations of supplemental β-carotene, retinol, vitamin A, lutein, and lycopene with lung cancer risk among participants, aged 50-76 years, in the VITamins And Lifestyle (VITAL) cohort Study in Washington State. In 2000-2002, eligible persons (n = 77,126) completed a 24-page baseline questionnaire, including detailed questions about supplement use (duration, frequency, dose) during the previous 10 years from multivitamins and individual supplements/mixtures. Incident lung cancers (n = 521) through December 2005 were identified by linkage to the Surveillance, Epidemiology, and End Results cancer registry. Longer duration of use of individual β-carotene, retinol, and lutein supplements (but not total 10-year average dose) was associated with statistically significantly elevated risk of total lung cancer and histologic cell types; for example, hazard ratio = 2.02, 95% confidence interval: 1.28, 3.17 for individual supplemental lutein with total lung cancer and hazard ratio = 3.22, 95% confidence interval: 1.29, 8.07 for individual β-carotene with small-cell lung cancer for >4 years versus no use. There was little evidence for effect modification by gender or smoking status. Long-term use of individual β-carotene, retinol, and lutein supplements should not be recommended for lung cancer prevention, particularly among smokers.
AB - High-dose β-carotene supplementation in high-risk persons has been linked to increased lung cancer risk in clinical trials; whether effects are similar in the general population is unclear. The authors examined associations of supplemental β-carotene, retinol, vitamin A, lutein, and lycopene with lung cancer risk among participants, aged 50-76 years, in the VITamins And Lifestyle (VITAL) cohort Study in Washington State. In 2000-2002, eligible persons (n = 77,126) completed a 24-page baseline questionnaire, including detailed questions about supplement use (duration, frequency, dose) during the previous 10 years from multivitamins and individual supplements/mixtures. Incident lung cancers (n = 521) through December 2005 were identified by linkage to the Surveillance, Epidemiology, and End Results cancer registry. Longer duration of use of individual β-carotene, retinol, and lutein supplements (but not total 10-year average dose) was associated with statistically significantly elevated risk of total lung cancer and histologic cell types; for example, hazard ratio = 2.02, 95% confidence interval: 1.28, 3.17 for individual supplemental lutein with total lung cancer and hazard ratio = 3.22, 95% confidence interval: 1.29, 8.07 for individual β-carotene with small-cell lung cancer for >4 years versus no use. There was little evidence for effect modification by gender or smoking status. Long-term use of individual β-carotene, retinol, and lutein supplements should not be recommended for lung cancer prevention, particularly among smokers.
KW - Beta carotene
KW - Carotenoids
KW - Cohort studies
KW - Dietary supplements
KW - Lung neoplasms
KW - Randomized controlled trials as topic
KW - Vitamins
UR - http://www.scopus.com/inward/record.url?scp=63149159259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=63149159259&partnerID=8YFLogxK
U2 - 10.1093/aje/kwn409
DO - 10.1093/aje/kwn409
M3 - Article
C2 - 19208726
AN - SCOPUS:63149159259
SN - 0002-9262
VL - 169
SP - 815
EP - 828
JO - American journal of epidemiology
JF - American journal of epidemiology
IS - 7
ER -